Ligand id: 9846

Name: mirikizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
10657 mirikizumab
Antibody I [US9023358] | LY-3074828 | LY3074828
Mirikizumab (LY-3074828) is a humanized monoclonal antibody against human IL-23A (IL-23p19) which is designed for the treatment of autoimmune diseases. It is one of the novel agents for immune-mediated inflammatory diseases discussed in Baker et al. (2018) [1]. The peptide sequences of mirikizumab heavy and light chains are 100% matches to sequences 9 and 10 of Antibody I that is claimed in patent US9023358 [2].
Database Links
Specialist databases
IMGT/mAb-DB 767
Other databases
GtoPdb PubChem SID 363894140
Search PubMed clinical trials mirikizumab
Search PubMed titles mirikizumab
Search PubMed titles/abstracts mirikizumab